Understanding rs1017182331: A Rare Intergenic Genetic Variant
The rs1017182331 variant is a rare genetic change located in an intergenic region of the human genome. It is currently being studied in large-scale databases to determine if it has any significant impact on human traits or health outcomes.
What each genotype means
Typical genetic profile
This genotype represents the most common form of this variant observed in general population studies. As this is an intergenic variant with limited evidence of clinical impact, this result is considered a standard genetic finding without known functional consequences.
This is the most frequently observed genotype across most global populations.
Rare variant carrier
You carry one copy of the less common allele for this variant. Because this variant is located in an intergenic region and is currently classified as having limited evidence for specific phenotypic associations, this finding is generally considered to be of uncertain significance.
This genotype is rare and observed at a low frequency in most ancestral groups.
Rare variant homozygous
You carry two copies of the less common allele for this variant. Current scientific literature does not associate this specific genotype with any established clinical traits or health conditions, and it remains a subject of ongoing genomic research.
This genotype is very rare and is found in only a small fraction of the population.
What is rs1017182331?
The rs1017182331 variant is a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. In the case of rs1017182331, the variant is classified as intergenic, meaning it is located in the non-coding DNA between genes. Because it does not sit within a gene that provides instructions for making proteins, it does not directly alter protein structure or function. Instead, researchers investigate such variants to see if they might influence how nearby genes are regulated or expressed. As a recently annotated variant, it is included in updated reference databases like dbSNP to facilitate ongoing scientific investigation. It is important to note that being listed in a database does not imply that the variant has a known biological effect; rather, it serves as a marker for researchers to track as they analyze the vast complexity of the human genome.
The Role of Intergenic Regions
For many years, the non-coding regions of the genome were often referred to as 'junk DNA,' but modern genomics has revealed that these areas are highly functional. Intergenic regions often contain regulatory elements, such as enhancers and promoters, which act like switches to turn genes on or off in specific tissues or at specific times. When a variant like rs1017182331 is identified, scientists look to see if it falls within these regulatory sequences. If a variant alters a binding site for a transcription factor, it could potentially change the expression levels of neighboring genes. However, because rs1017182331 is currently categorized as a trait-associated variant with limited evidence, its specific functional role remains unknown. Ongoing research in functional genomics is essential to determine if this specific location in the genome plays any part in biological processes or if it is simply a neutral variation that has persisted in the population.
Evidence and Research Status
The evidence supporting a link between rs1017182331 and any specific health trait or condition is currently classified as moderate. In the world of genomics, 'moderate' evidence often means that while the variant has been flagged in large-scale studies, it has not been definitively linked to a specific disease or clinical outcome in a way that would change medical practice. Most variants identified in genome-wide association studies (GWAS) require replication across diverse populations to confirm their significance. Because rs1017182331 is rare, it is difficult for researchers to gather enough data to draw firm conclusions. It is common for many variants to be cataloged in databases like ClinVar or the GWAS Catalog long before their true biological impact is understood. Consequently, this variant should be viewed as a subject of ongoing scientific inquiry rather than a diagnostic marker for any health condition.
Population Frequency and Interpretation
The rs1017182331 variant is noted for being rare across human populations. In genomics, rarity often makes it challenging to study, as there are fewer individuals carrying the variant to compare against those who do not. Large-scale projects like the Genome Aggregation Database (gnomAD) provide the data necessary to estimate how often these variants appear in different ancestral groups. When a variant is rare, it may be found only in specific populations or may be distributed very sparsely across the globe. Understanding the frequency of a variant is a critical first step in determining its potential impact; if a variant is extremely rare, it is less likely to be a major driver of common, complex diseases. Readers should be aware that population frequency data is constantly being updated as more genomes are sequenced, providing a clearer picture of human genetic diversity over time.
What You Can Do With This Information
If you have encountered rs1017182331 in a personal genetic report, it is important to maintain perspective. Because this variant is intergenic and lacks strong clinical evidence, it is not currently used to predict health risks or guide medical decisions. Genetic information can be complex, and it is easy to over-interpret findings that are still being researched. You cannot use this information to diagnose yourself or make changes to your health regimen. If you are concerned about your genetic health or family history, the best course of action is to consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your results in the context of your overall health, lifestyle, and medical history. Always prioritize professional medical advice over information found in online databases, which are intended for research and educational purposes rather than clinical application.
How common is this variant?
The rs1017182331 variant is classified as rare, meaning it appears at a very low frequency across global populations in current genomic databases.
Frequently asked questions
Is rs1017182331 associated with a specific disease?
Currently, there is no definitive evidence linking rs1017182331 to any specific disease. It is categorized as a trait-associated variant with moderate evidence, meaning more research is needed to understand its role.
Should I be worried if I have this variant?
No, there is no reason for concern. Most genetic variants, especially those in intergenic regions, have no known impact on health. This variant is primarily of interest to researchers studying the human genome.
Can I use this information to change my diet or medication?
No. You should never use information about a single genetic variant to make changes to your diet or medication. Always discuss any health-related concerns with your clinician or pharmacist.
Where can I find more information about this SNP?
You can look up the variant on the NCBI dbSNP database or the GWAS Catalog. These resources provide the most up-to-date scientific information regarding its genomic location and research status.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1017182331?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
An intronic regulatory variant in the LPP gene strongly associated with serum allergen-specific IgE levels and allergic rhinitis susceptibility.
A well-replicated intronic polymorphism in LPP associated with multi-allergen sensitization, including cat dander, dust mites, and grass pollen.
This intronic variant in the CASP8 gene is linked to prostate cancer risk assessment models.
This intronic variant is associated with improved risk stratification for clinically significant prostate cancer.
An intronic variant in the ITGA6 gene identified as a marker for prostate cancer risk stratification.
This variant is significantly associated with increased risk of mortality in coronary artery disease patients.